Bank Of America Corp Kal Vista Pharmaceuticals, Inc. Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 62,507 shares of KALV stock, worth $713,204. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,507
Previous 23,955
160.94%
Holding current value
$713,204
Previous $284,000
159.15%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding KALV
# of Institutions
122Shares Held
47.4MCall Options Held
71.8KPut Options Held
26.3K-
Vr Adviser, LLC New York, NY6.25MShares$71.3 Million8.08% of portfolio
-
Tang Capital Management LLC San Diego, CA4.22MShares$48.1 Million6.07% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.19MShares$47.8 Million2.06% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.69MShares$42.1 Million2.56% of portfolio
-
Capital World Investors Los Angeles, CA3.23MShares$36.8 Million0.01% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $281M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...